{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:54:27Z","timestamp":1769100867251,"version":"3.49.0"},"reference-count":31,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2023,12,25]]},"DOI":"10.4274\/tjps.galenos.2023.71242","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T14:55:17Z","timestamp":1693234517000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Development and Evaluation of Methotrexate and Baicalin Loaded Nano- Lipid Carriers for Psoriasis Treatment"],"prefix":"10.4274","volume":"0","author":[{"given":"Sundus","family":"Sohail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloma","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidra","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Junaid","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"issue":"1","key":"ref0","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/1757975920977874","article-title":"The health and economic burden of the coronavirus in sub-Saharan Africa","volume":"28","author":"BKY","year":"2021","unstructured":"1. Bitanihirwe BKY, Ssewanyana D. The health and economic burden of the coronavirus in sub-Saharan Africa. Glob Health Promot. 2021;28(1):70-4.","journal-title":"Glob Health Promot"},{"key":"ref1","unstructured":"2. UNHCR. Cameroon Situation [Internet]. 2020. p. 1-6. Available from: https:\/\/covid19.who.int\/region\/afro\/country\/cm"},{"key":"ref2","unstructured":"3. Worldometer. Covid-19 Coronavirus Pandemic. Coronavirus [Internet]. Available from: https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"ref3","unstructured":"4. OMS. L'OMS recommande un traitement tr\u00e8s efficace contre la COVID-19 et appelle son initiateur \u00e0 en assurer une large distribution g\u00e9ographique et \u00e0 faire preuve de transparence. [Internet]. 2022. Available from: https:\/\/www.who.int\/fr\/news\/item\/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Kashte S, Gulbake A, El-Amin SF, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell [Internet]. 2021;34(3):711-33. Available from: https:\/\/doi.org\/10.1007\/s13577-021-00512-4","DOI":"10.1007\/s13577-021-00512-4"},{"key":"ref5","unstructured":"6. World Health Organisation (WHO). COVID-19 vaccine tracker and landscape. Ultrasound Med Biol [Internet]. 2021;41(11):2990-3000. Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"ref6","unstructured":"7. Diclofenac-containing medicines | European Medicines Agency [Internet]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/diclofenac-containing-medicines"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Gbeasor-Komlanvi FA, Afanvi KA, Konu YR, Agbobli Y, Sadio AJ, Tchankoni MK, et al. Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021. Public Heal Pract [Internet]. 2021;2(February):100220. Available from: https:\/\/doi.org\/10.1016\/j.puhip.2021.100220","DOI":"10.1016\/j.puhip.2021.100220"},{"key":"ref8","unstructured":"9. WHO. Report of the Sage Working Group on. WHO COVID-19 Glob data [Internet]. 2014;(October):64. Available from: https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Kabagenyi A, Wasswa R, Nannyonga BK, Nyachwo EB, Kagirita A, Nabirye J, et al. Factors Associated with COVID-19 Vaccine Hesitancy in Uganda: A Population-Based Cross-Sectional Survey. Int J Gen Med. 2022;15(August):6837-47.","DOI":"10.2147\/IJGM.S372386"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Sherman SM, Smith LE, Sim J, Aml\u00f4t R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccines Immunother [Internet]. 2021;17(6):1612-21. Available from: https:\/\/doi.org\/10.1080\/21645515.2020.1846397","DOI":"10.1080\/21645515.2020.1846397"},{"key":"ref11","unstructured":"12. April S. The Access to COVID-19 Tools ( ACT ) Accelerator. 2020;(April)."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol [Internet]. 2020;35(4):325-30. Available from: https:\/\/doi.org\/10.1007\/s10654-020-00634-3","DOI":"10.1007\/s10654-020-00634-3"},{"issue":"34","key":"ref13","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","unstructured":"14. MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4.","journal-title":"Vaccine"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9020175","article-title":"Assessment of vaccine hesitancy to a covid-19 vaccine in cameroonian adults and its global implication","volume":"9","author":"Dinga","year":"2021","unstructured":"15. Dinga JN, Sinda LK, Titanji VPK. Assessment of vaccine hesitancy to a covid-19 vaccine in cameroonian adults and its global implication. Vaccines. 2021;9(2):1-14.","journal-title":"Vaccines"},{"key":"ref15","unstructured":"16. Ritchie H MER-GLACGCO-OE et al. Coronavirus (COVID-19) Vaccinations - Our World in Data [Internet]. 2020. Available from: https:\/\/ourworldindata.org\/covid-vaccinations"},{"key":"ref16","unstructured":"17. Gavi the Vaccine Alliance. COVID-19 Vaccine Global Access (COVAX) Facility - Primary technical design. 2020;(June):1-33."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Sol\u00eds Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med [Internet]. 2021;27(8):1385-94. Available from: http:\/\/dx.doi.org\/10.1038\/s41591-021-01454-y","DOI":"10.1038\/s41591-021-01454-y"},{"key":"ref18","unstructured":"19. INS. Equ\u00eate D\u00e9mographique et de Sant\u00e9 [Internet]. Rockville, Maryland; 2018. Available from: https:\/\/dhsprogram.com\/pubs\/pdf\/FR360\/FR360.pdf"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine [Internet]. 2021;40:101113. Available from: https:\/\/doi.org\/10.1016\/j.eclinm.2021.101113","DOI":"10.1016\/j.eclinm.2021.101113"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.2147\/RMHP.S338520","article-title":"Determinants of Hesitancy Towards COVID-19 Vaccines in State of Kuwait: An Exploratory Internet-Based Survey","volume":"14","author":"Al-Ayyadhi","year":"2021","unstructured":"21. Al-Ayyadhi N, Ramadan MM, Al-Tayar E, Al-Mathkouri R, Al-Awadhi S. Determinants of Hesitancy Towards COVID-19 Vaccines in State of Kuwait: An Exploratory Internet-Based Survey. Risk Manag Healthc Policy. 2021;14:4967-81.","journal-title":"Risk Manag Healthc Policy"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/irv.12847","article-title":"COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population","volume":"15","author":"Alabdulla","year":"2021","unstructured":"22. Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population. Influenza Other Respi Viruses. 2021;15(3):361-70.","journal-title":"Influenza Other Respi Viruses"},{"issue":"7","key":"ref22","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1002\/jmv.26910","article-title":"Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students","volume":"93","author":"Saied","year":"2021","unstructured":"23. Saied SM, Saied EM, Kabbash IA, Abdo SAEF. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280-91.","journal-title":"J Med Virol"},{"issue":"2","key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9020153","article-title":"Covid-19 vaccine acceptance in the democratic republic of congo: A cross-sectional survey","volume":"9","author":"Ditekemena","year":"2021","unstructured":"24. Ditekemena JD, Nkamba DM, Mutwadi A, Mavoko HM, Fodjo JNS, Luhata C, et al. Covid-19 vaccine acceptance in the democratic republic of congo: A cross-sectional survey. Vaccines. 2021;9(2):1-11.","journal-title":"Vaccines"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Moola S, Gudi N, Nambiar D, Dumka N, Ahmed T, Sonawane IR, et al. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries. J Glob Health. 2021;11.","DOI":"10.7189\/jogh.11.05027"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Wake AD. The Acceptance Rate Toward COVID-19 Vaccine in Africa: A Systematic Review and Meta-analysis. Glob Pediatr Heal. 2021;8.","DOI":"10.1177\/2333794X211048738"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Hossain MA, et al. Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage. PLoS One [Internet]. 2021;16(4 April 2021):1-17. Available from: http:\/\/dx.doi.org\/10.1371\/journal.pone.0250495","DOI":"10.1371\/journal.pone.0250495"},{"key":"ref27","unstructured":"28. Xing, Yu-Han; Ni, Wei; Wu, Qin; Li, Wen-Jie; Li, Guo-Ju; Wang, Wen-Di; Tong, Jian-Ning; Song, Xiu-Feng; Wong, Gary Wing-Kin; Xing Q-S. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. Ann Oncol. 2020;7(May):19-21."},{"key":"ref28","unstructured":"29. Ne'eman A. AMA Journal of Ethics 2019. AMA J Ethics. 2021;21(1):590-5."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.2147\/IDR.S331434","article-title":"Traditional medicine practice in the context of covid-19 pandemic: Community claim in jimma zone, oromia, ethiopia","volume":"14","author":"Chali","year":"2021","unstructured":"30. Chali BU, Melaku T, Berhanu N, Mengistu B, Milkessa G, Mamo G, et al. Traditional medicine practice in the context of covid-19 pandemic: Community claim in jimma zone, oromia, ethiopia. Infect Drug Resist. 2021;14:3773-83.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"ref30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4269\/ajtmh.20-1488","article-title":"Perspective piece COVID-19 misinformation and infodemic in Rural Africa","volume":"104","author":"Okereke","year":"2021","unstructured":"31. Okereke M, Ukor NA, Ngaruiya LM, Mwansa C, Alhaj SM, Ogunkola IO, et al. Perspective piece COVID-19 misinformation and infodemic in Rural Africa. Am J Trop Med Hyg. 2021;104(2):453-6.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T12:59:19Z","timestamp":1726145959000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2023.71242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":31,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2023,12,25]]},"published-print":{"date-parts":[[2023,12,25]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2023.71242","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"value":"1304-530X","type":"print"},{"value":"2148-6247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}